Analysis shows reduced mortality risk associated with ESBL-producing E. coli bacteraemia after adjustments, suggesting improved outcomes with proper therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Olivares-Navarro et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: